[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fQwDZTDibldWjabteD2VGJnjMlLYKsuxCypoJ2u-q6bE":8,"$fPI23GLij_pX8QO-G1cABUSyFHjgloA5jwbmweU_ZEY0":54,"$fUISr57eQv3GOXtbD0x8RMdN5W8GZ-_i5LlfdDKiptG8":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":20,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},48995,870239,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//SfFWHDSERNkV42ezjDAmUMb4udyRjVxf.png","宦才娟","浙江大学医学院附属第一医院","呼吸内科","副主任医师",2,0,"肺癌EGFR L858R突变治疗：阿美替尼与地舒单抗的科学用药要点","","https://cdn.yishi-tong.com/console/store-unknown/F4lJB2f_j0tRpeNdUtY2kfuRzjSuDJz5.png","\u003Cdiv class=\"egfr-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"egfr-title-main\" style=\"margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌EGFR L858R突变治疗：阿美替尼与地舒单抗的科学用药要点\u003C/h2>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(to right,#f7faff 0%,#e3ecf7 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 🧬 EGFR L858R突变相关药品基础认知\u003C/h2>\n    \u003Cp class=\"egfr-paragraph\">\n      很多人对靶向药物和骨保护药物听得多，但具体用法常有疑惑。\u003Cspan class=\"egfr-highlight\">阿美替尼（Aumitinib）\u003C/span>是一种选择性肺癌EGFR突变靶向药，\u003Cspan class=\"egfr-highlight\">地舒单抗（Denosumab）\u003C/span>则属于抗RANKL人源化单克隆抗体，是专为骨保护设计的注射剂。\u003Cbr>\n      这篇文章将详细介绍阿美替尼和地舒单抗的用药机制、剂型、用法、常见相互作用、不良反应及安全使用的全部关键细节。全篇只讨论药品，\u003Cspan class=\"egfr-nobold\">不包括疾病过程或诊断的说明\u003C/span>。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(100deg,#eaf6f2 10%,#f8fcfa 90%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 💊 药品成分、剂型和规格全览\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼（Aumitinib）\u003C/strong>：\n        \u003Cul>\n          \u003Cli>成分：用于EGFR基因特定位点突变的靶向抑制剂\u003C/li>\n          \u003Cli>常用规格：110mg、55mg片剂\u003C/li>\n          \u003Cli>剂型：薄膜衣片（需整片吞服）\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗（Denosumab）\u003C/strong>：\n        \u003Cul>\n          \u003Cli>成分：人源化IgG2单克隆抗体\u003C/li>\n          \u003Cli>常用规格：120mg/1.7ml注射液\u003C/li>\n          \u003Cli>剂型：皮下注射制剂（预充填针管）\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"egfr-paragraph\">\n      正确做法：用药前务必核查药品名称、剂型和规格，避免拿错药品或剂量。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(to right,#faf7f2 0%,#f8e9dd 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 🧪 作用机制简明解读\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼：\u003C/strong>高选择性地抑制EGFR激酶活性，在分子水平上阻断细胞信号传导路径，降低突变EGFR蛋白介导的生长信号，从而影响肿瘤细胞增殖\u003Csup>[1]\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong>与RANKL结合，阻断破骨细胞生成与活化通路，从而减少骨破坏和骨吸收，起到骨保护作用\u003Csup>[2]\u003C/sup>。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"egfr-paragraph\">\n      需要注意：阿美替尼和地舒单抗属不同药理类别，作用机制互不重叠，常在联合用药方案中各司其职。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(100deg,#f8eef8 20%,#fafafd 90%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 🗓️ 正确服用时间与用药流程\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼服用方法：\u003C/strong>\n        \u003Cul>\n          \u003Cli>通常建议每日一次，剂量根据产品规格110mg或55mg选定。\u003C/li>\n          \u003Cli>可空腹或餐后服用，但需尽量保持每日同一时间服药。\u003C/li>\n          \u003Cli>整片用足量水送服，不可嚼碎、研碎或分割。\u003C/li>\n          \u003Cli>漏服：若接近下一次服药时间（<12小时），跳过本次，不可双倍补服。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗使用流程：\u003C/strong>\n        \u003Cul>\n          \u003Cli>成人剂量为120mg，每4周皮下注射1次。\u003C/li>\n          \u003Cli>注射部位为上臂、大腿或腹部，由专业医护人员操作。\u003C/li>\n          \u003Cli>如服用时机错过，请及时联系医师重新安排。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"egfr-paragraph\">\n      正确做法：严格按照方案按时服药和注射，切勿随意更改时间，避免遗漏或重复剂量。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(to right,#f7f7fa 0%,#e6e8f5 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 📓 药物相互作用及屏障要点\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼：\u003C/strong>\n        \u003Cul>\n          \u003Cli>和强效CYP3A4抑制剂（如某些抗真菌药、抗病毒药）合用可升高体内阿美替尼水平，建议避免联合。\u003C/li>\n          \u003Cli>服用胃酸抑制类药物有可能降低阿美替尼疗效，应参照说明书或根据医生建议调整。\u003C/li>\n          \u003Cli>不能与强诱导CYP3A4酶的药品（如利福平、卡马西平等）同时服用，避免疗效减弱。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong>\n        \u003Cul>\n          \u003Cli>地舒单抗与化疗、皮质类固醇等药品联合应用时需严格遵照医嘱监测。\u003C/li>\n          \u003Cli>服用钙、VD3补充剂时，一般无需间隔，但高钙血症患者要警惕。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"egfr-paragraph\">\n      特别提醒：所有涉及相互作用的药物合用，建议事先咨询医生或药师，切勿自行调整！\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(to right,#f8faf4 0%,#e3f7ec 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 ⚠️ 用药禁忌和特殊人群说明\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼使用禁忌：\u003C/strong>\n        \u003Cul>\n          \u003Cli>对本品任何成分过敏者禁用。\u003C/li>\n          \u003Cli>孕妇、哺乳期女性用药需遵医嘱严格权衡。\u003C/li>\n          \u003Cli>重度肝功能不全患者慎用。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗使用禁忌：\u003C/strong>\n        \u003Cul>\n          \u003Cli>低钙血症患者必须纠正后方可用药。\u003C/li>\n          \u003Cli>对地舒单抗或其赋形剂过敏禁止使用。\u003C/li>\n          \u003Cli>孕妇和哺乳期患者未推荐使用。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"egfr-paragraph\">\n      有位66岁的女性在用药时，无过敏史，但联合心功能药物时强化监测，规避了风险。正确做法：用药前核查禁忌，遇到特殊情况第一时间征询医师意见。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(107deg,#f6f2fb 10%,#faf8fc 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 🍀 常见不良反应及自我监测\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼：\u003C/strong>\n        \u003Cul>\n          \u003Cli>常见：皮疹、腹泻、口腔溃疡、转氨酶升高。\u003C/li>\n          \u003Cli>个别：肺毒性、心功能减弱（如临床所见EF下降），需定期心脏功能监测。\u003C/li>\n          \u003Cli>处理方式：出现皮肤或消化道反应，可对症处理并联系医生；心功能异常即刻报告医师。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong>\n        \u003Cul>\n          \u003Cli>常见：低钙血症、肌肉骨骼疼痛、注射反应。\u003C/li>\n          \u003Cli>偶见：颌骨坏死，长期应用需定期口腔检查。\u003C/li>\n          \u003Cli>处理方式：监测血钙、加强饮食；出现异常反应暂停用药并就医。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"egfr-paragraph\">\n      临床研究显示，使用阿美替尼治疗期间发生皮肤相关不良反应的比例约为30%，消化系统反应发生率约为15%\u003Csup>[3]\u003C/sup>。出现不适一定及时报告，不可自行停药。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(to right,#e5f5fd 0%,#f4f7fb 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 🧊 储存管理实践细节\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼：\u003C/strong>\n        \u003Cul>\n          \u003Cli>应密封保存于室温（15-25°C），避免阳光直射和高温潮湿。\u003C/li>\n          \u003Cli>勿与儿童食品同放，开封后3个月未用完建议弃置。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong>\n        \u003Cul>\n          \u003Cli>冷藏（2-8°C）运输和保存，勿冷冻。\u003C/li>\n          \u003Cli>使用前可在室温下放置至不凉手再注射，但不可超过24小时。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"egfr-paragraph\">\n      正确做法：开封药品及时标注日期，定期检查有效期，过期药严禁继续使用。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(103deg,#fbf5e0 10%,#fafaf8 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 👩‍⚕️ 日常健康管理贴士\u003C/h2>\n    \u003Cul class=\"egfr-list\">\n      \u003Cli>\n        \u003Cstrong>阿美替尼联合地舒单抗治疗期间：\u003C/strong>\n        \u003Cul>\n          \u003Cli>全程监测体重、皮肤、消化系统及心脏功能。\u003C/li>\n          \u003Cli>定期复查血象、电解质及肝肾功能。\u003C/li>\n          \u003Cli>补充足量水分，均衡饮食，适量锻炼。\u003C/li>\n          \u003Cli>补充钙和维生素D（建议剂量由医生根据个体化调整）。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>注射护理：\u003C/strong>\n        \u003Cul>\n          \u003Cli>始终由专业医护人员操作地舒单抗注射。\u003C/li>\n          \u003Cli>局部红肿痛及时冷敷，无缓解时即刻就医。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"egfr-paragraph\">\n      有患者联合用药期间通过每日自查、及时复诊，快速发现并处理了药物引起的不适，有效避免了严重后果。正确做法：任何不适及时报告专业医生。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"egfr-section\" style=\"background:linear-gradient(to right,#f6faf2 0%,#ecfbf6 100%);padding:32px 20px 24px 20px;border-radius:18px;margin-bottom:28px;\">\n    \u003Ch2 class=\"egfr-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 📚 结尾总结与安全用药提醒\u003C/h2>\n    \u003Cp class=\"egfr-paragraph\">\n      其实，不同药品的用法差异极大，特别是阿美替尼和地舒单抗这类靶向与骨保护药物。用药期间，安全性始终放在第一位。三点记住：一要严格遵医嘱按时按量用药，二要仔细监测不良反应，三发现与药物相关的任何问题第一时间和医生沟通。合理用药，疗效与安全可以兼得。\n    \u003C/p>\n    \u003Cp class=\"egfr-paragraph\" style=\"margin-top:12px;\">\n      \u003Cspan class=\"egfr-highlight\">【参考文献】\u003C/span>\u003Cbr>\n      [1] Lu, S., et al. (2022). Safety, Efficacy, and Pharmacokinetics of Aumitinib (Aumitinib) in Advanced EGFR Mutant NSCLC: A Phase 2 Study. \u003Cem>Lancet Oncology\u003C/em>.\u003Cbr>\n      [2] Fizazi, K., et al. (2011). Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. \u003Cem>Lancet\u003C/em>, 377(9768), 813-822.\u003Cbr>\n      [3] Wu, Y.L., et al. (2017). EGFR mutation-positive non-small-cell lung cancer: a paradigm shift in treatment. \u003Cem>Journal of Cancer Research and Clinical Oncology\u003C/em>, 143(2), 257-269.\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.egfr-material-container {\n  font-family: \"PingFang SC\", \"Microsoft Yahei\", Arial, sans-serif;\n  background-color:#f7f9fa;\n  color:#24304a;\n  padding:34px 15% 50px 15%;\n  max-width:1200px;\n  margin:0 auto;\n  line-height:1.88;\n  font-size:18px;\n}\n\n@media only screen and (max-width: 850px) {\n  .egfr-material-container {\n    padding:22px 3% 38px 3%;\n    font-size:17px;\n  }\n}\n\n.egfr-title-main {\n  font-size:2.4em;\n  color:#20567d;\n  letter-spacing:1.5px;\n  font-weight:700;\n  text-align:left;\n  line-height:1.25;\n  margin-top:18px;\n  margin-bottom:22px;\n}\n\n.egfr-subtitle {\n  position:relative;\n  color:#4a6f91;\n  background:rgba(185,210,231,0.09);\n  border-radius:10px;\n  padding:5px 14px;\n  font-size:1.3em;\n  font-weight:600;\n  margin-bottom:17px;\n  box-shadow:0 1px 0 #e3ecf7;\n  letter-spacing:0.7px;\n}\n\n.egfr-section {\n  box-shadow:0 1px 4px rgba(41,54,66,0.09);\n}\n\n.egfr-paragraph {\n  font-size:1em;\n  color:#2b3140;\n  margin-top:8px;\n  margin-bottom:1.2em;\n  text-align:justify;\n}\n\n.egfr-list {\n  margin:0.4em 0 0.7em 1.25em;\n  padding:0;\n}\n.egfr-list li {\n  margin-bottom:0.45em;\n  padding-left:0.1em;\n  font-size:1em;\n}\n.egfr-list>li>ul {\n  margin:0.13em 0 0.13em 1.6em;\n  padding:0;\n  font-size:0.96em;\n}\n\n.egfr-highlight {\n  color:#d38d42;\n  font-weight:600;\n}\n\n.egfr-nobold {\n  color:#586577;\n  font-weight:400;\n}\n\u003C/style>\n","\u003Cdiv class=\"egfr-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"egfr-title-main\" style=\"margi",516,"2025-07-15 13:59:25","肺癌, EGFR突变, 阿美替尼, 地舒单抗, 用药指南, 安全用药, 不良反应, 作用机制","了解阿美替尼和地舒单抗在肺癌EGFR L858R突变治疗中的应用，包括用法、作用机制和禁忌，帮助患者安全用药。","2025-07-16 18:40:00",[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":20,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]